• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926216300
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/30/2017
Event Type  malfunction  
Manufacturer Narrative
Device is a combination product.  (b)(4).Device evaluated by mfr: a synergy ous mr 3.00 x 16 mm stent delivery catheter (sdc) was returned for analysis without a stent.There was no stent on the balloon.The balloon was reviewed and no damage was noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.Stent crimp markings were evident on the balloon indicating correct positioning and crimping of the stent prior to the complaint incident.A visual and tactile examination of the hypotube found no issues.A visual and tactile examination of shaft polymer extrusion found no issues.A visual and microscopic examination of the tip found damage to the tip.No other issues were identified during the product analysis.The manufacturing crimp data for this device was reviewed and the crimping process & controls did not highlight any anomalies.The investigation conclusion is handling damage as the complaint was caused by handling of the device or portion of the device without direct patient contact.  (b)(4).
 
Event Description
Reportable based on device analysis completed on 01-dec-2017.It was reported that crossing difficulties were encountered.The 85% stenosed target lesion was located in the severely tortuous and severely calcified right coronary artery (rca).After predilation was performed, a 3.00 x 16mm synergy¿ drug-eluting stent was advanced but failed to cross the lesion.The procedure was completed with another synergy stent.No patient complications were reported and the patient's status was stable.However, returned device analysis revealed stent detachment.It was further reported that after removal of the device from the patient's body, it was separated from the delivery system while the physician was checking the stent status.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7138584
MDR Text Key95611764
Report Number2134265-2017-12409
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeKR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 12/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/02/2019
Device Model NumberH7493926216300
Device Catalogue Number39262-1630
Device Lot Number20883983
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/20/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/27/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age55 YR
-
-